|
2013 Conference Publication Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomasRowe, C. J., Rodero, M., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2013). Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomas. The Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney, NSW Australia, 19 – 22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12051 |
|
2013 Conference Publication Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01)Henderson, Michael A., Burmeister, Bryan, Ainslie, Jill, Fisher, Richard, Di Iulio, Julianna, Smithers, Bernard Mark, Hong, Angela, Shannon, Kerwin F., Scolyer, Richard A., Carruthers, Scott, Coventry, Brendon J., Babington, Scott, Duprat, Joao, Hoekstra, Harald J. and Thompson, John F. (2013). Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago IL United States, May 31-Jun 04, 2013. United States: American Society of Clinical Oncology. |
|
2013 Conference Publication Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengalAgarwala, S., Thompson, J. F., Smithers, B. M., Ross, M. I., Coventry, B. J., Minor, D. R., Scoggins, C. R., Singer, J. M. and Wachter, E. A. (2013). Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengal. 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam Netherlands, Sep 27-Oct 01, 2013. Oxford United Kingdom: Pergamon. doi: 10.1016/S0959-8049(13)70065-0 |
|
2013 Conference Publication Survival and recurrence outcome in patients with melanomas of unknown primary invading lymph nodesWright, A., Hughes, M., Siskind, V., Smithers, M., Thomas, J., Green, A. and Khosrotehrani, K. (2013). Survival and recurrence outcome in patients with melanomas of unknown primary invading lymph nodes. The Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney, NSW Australia, 19 – 22 May 2013. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/ajd.12051 |
|
2012 Conference Publication TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG)Leong, Trevor, Smithers, Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Zalcberg, John Raymond, Wong, Rebecca and Haustermans, Karin (2012). TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Conference Publication TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG)Leong, Trevor, Smithers, Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Zalcberg, John Raymond, Wong, Rebecca and Haustermans, Karin (2012). TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Conference Publication Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastasesMorton, Donald L., Mozzillo, Nicola, Kashani-Sabet, Mohammed, Thompson, John F., Kelley, Mark C., De Conti, Ronald C., Lee, Jeffrey Edwin, Huth, James F., Faries, Mark B., Dalgleish, Angus George, Wagner, Jeffrey D., Hersh, Evan, Schneebaum, Schlomo, Anderson, Clay M., Smithers, Mark, Schuchter, Lynn Mara, McMasters, Kelly M., Testori, Alessandro, Karakousis, C. P. and Elashoff, Robert (2012). Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastases. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2012 Conference Publication DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junctionBarbour, Andrew, Smithers, Bernard Mark, Burmeister, Bryan, Zalcberg, John Raymond, Spry, Nigel, Smith, Garrett, Wilson, Kate, Roff, Kate, Yip, Sonia and Walpole, Euan Thomas (2012). DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junction. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2012 Conference Publication Immuno-chemoablation of metastatic melanoma with intralesional Rose BengalAgarwala, S. S., Thompson, J. F., Smithers, B. M., Ross, M., Coventry, B. J., Minor, D. R., Scoggins, C. R. and Wachter, E. (2012). Immuno-chemoablation of metastatic melanoma with intralesional Rose Bengal. 37th Congress of the European Society for Medical Oncology (ESMO), Vienna Austria, 28 September-02 October 2012. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mds404 |
|
2012 Conference Publication Activation of stat5 is an indicator of good prognosis in stage Ib and II melanomasRodero, M., Wright, A., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2012). Activation of stat5 is an indicator of good prognosis in stage Ib and II melanomas. The Australasian College of Dermatologists 45th Annual Scientific Meeting, Brisbane, QLD, Australia, 20-23 May 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-0960.2012.00892.x |
|
2012 Conference Publication MAGE-A3 expression in patients screened for the DERMA trial: a phase III trial testing MAGE-A3 immunotherapeutic in the adjuvant setting for stage IIIB-C-Tx melanomaThompson, John F., Santinami, Mario, Jouary, Thomas, Levchenko, Eugeny, Smithers, Bernard Mark, Mortier, Laurent, Grob, Jean Jacques, Trefzer, Uwe, Gutzmer, Ralf, Jamoul, Corinne, Peeters, Olivier, Dreno, Brigitte and Kirkwood, John M. (2012). MAGE-A3 expression in patients screened for the DERMA trial: a phase III trial testing MAGE-A3 immunotherapeutic in the adjuvant setting for stage IIIB-C-Tx melanoma. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Illinois, 1-6 June 2012 . Alexandria, VA, United States : American Society of Clinical Oncology. |
|
2012 Conference Publication Melanoma brain metastases: the impact of nodal diseaseJackson, J., Burmeister, B. H., Burmeister, E., Foote, M. C., Thomas, J. M. and Smithers, B. M. (2012). Melanoma brain metastases: the impact of nodal disease. 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Boston, MA United States, 28-31 October 2012. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.ijrobp.2012.07.1748 |
|
2012 Conference Publication Gene expression analysis of EAC in association with PET response.Wayte, Nicola, Nancarrow, Derek, Walpole, Euan Thomas, Lampe, Guy, Gotley, David, Smithers, Bernard Mark and Barbour, Andrew (2012). Gene expression analysis of EAC in association with PET response.. ASCO GI Symposium, San Diego, California, 24 January 2012. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/jco.2012.30.4_suppl.50 |
|
2011 Conference Publication Dermoscopic naevus patterns by age and body site in the high risk and general Queensland populationsDouglas, N. C., Borgovan, T., Carroll, M. J., Siskind, V., Wurm, E. M. T., Smithers, B. M., Green, A. C. and Soyer, H. P. (2011). Dermoscopic naevus patterns by age and body site in the high risk and general Queensland populations. MALDEN: WILEY-BLACKWELL. |
|
2011 Conference Publication A phase I, open-label, cohort study of two doses of coxsackievirus A21 given intratumorally in stage IV melanoma.Shafren, D., Smithers, B. M. and Formby, M. (2011). A phase I, open-label, cohort study of two doses of coxsackievirus A21 given intratumorally in stage IV melanoma.. 2011 ASCO Annual Meeting, Chicago, Illinois, 3-7 June 2011. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/jco.2011.29.15_suppl.8573 |
|
2010 Conference Publication Chemoablation of metastatic melanoma with rose bengal (PV-10)Agarwala, S. S., Thompson, J. F., Smithers, B. M., Rose, M. I., Coventry, B. J., Minor, D. R., Scoggins, C. R. and Wachter, E. A. (2010). Chemoablation of metastatic melanoma with rose bengal (PV-10). Melanoma 2010 Congress, Sydney, Australia, 4-7 November 2010. Alexandria, VA, United States: American Society of Clinical Oncology . |
|
2009 Conference Publication Successful management of an aortoesophageal fistula caused by a fish bone - Case report and review of literatureKelly, Stephen L., Peters, Paul, Ogg, Murray J., Li, Alan and Smithers, Bernard M. (2009). Successful management of an aortoesophageal fistula caused by a fish bone - Case report and review of literature. Conjoint Annual Scientific Congress of the Royal Australian College of Surgeons/College of Surgeons of Hong Kong, Hong Kong, Peoples Republic of China, May 2008. London, United Kingdom: BioMed Central. doi: 10.1186/1749-8090-4-21 |
|
2009 Conference Publication Chemoablation of melanoma with intralesional rose bengal (PV-10)Agarwala, S. S., Thompson, J., Smithers, M., Ross, M., Coventry, B., Minor, D., Scoggins, C., Hersey, P. and Wachter, E. (2009). Chemoablation of melanoma with intralesional rose bengal (PV-10). 45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, U.S.A., 29 May - 2 June 2009. Alexandria, VA, U.S.A.: American Society of Clinical Oncology. |
|
2009 Conference Publication Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy: Results of an Intergroup Randomized Trial (TROG 02.01/ANZMTG 01.02)Burmeister, B., Henderson, M., Thompson, J., Fisher, R., Di Iulio, J., Smithers, M., Hong, A., Carruthers, S., Hoekstra, H. and Ainslie, J. (2009). Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy: Results of an Intergroup Randomized Trial (TROG 02.01/ANZMTG 01.02). 51st Annual Meeting of the American-Society-for-Radiation-Oncology, Chicago, IL, 1-5 November 2009. United States: Elsevier. doi: 10.1016/j.ijrobp.2009.07.031 |
|
2008 Conference Publication Minimally invasive esophagectomy for esophageal cancer: Analysis of recurrence patterns and prognostic factors of recurrenceBarbour, A., Thompson, I., Gotley, D. C., Jones, M., Thomas, J., Martin, I. and Smithers, M. B. (2008). Minimally invasive esophagectomy for esophageal cancer: Analysis of recurrence patterns and prognostic factors of recurrence. Clinical Oncological Society of Australia and the International Association of Cancer Registries Joint Scientific Meeting, held in conjunction with the Australian and New Zealand Gastro-Oesophageal Surgery Association, Sydney, Australia, 18–20 November 2008. United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/j.1743-7563.2008.00201_2.x |
